Development

Search documents
NeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment
Globenewswire· 2025-07-10 13:00
CALABASAS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, today announced it has achieved a key milestone toward closing its previously announced strategic transaction with Quazar Investment: formal approval from NeOnc’s Board of Directors. On June 30, 2025, NeOnc’s Board unanimously approved the company’s participation in the contemplated $50 ...
FTRE COURT NOTICE: Fortrea Holdings Inc. Investors may have been Affected by Fraud – Contact BFA Law by the August 1 Legal Deadline (NASDAQ:FTRE)
GlobeNewswire News Room· 2025-07-10 12:18
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...
Plexus Sets Fiscal Third Quarter 2025 Earnings Release Date
Globenewswire· 2025-07-09 20:15
NEENAH, WI, July 09, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal third quarter 2025 results after market close on Wednesday, July 23, 2025. Plexus’ management will host a conference call to discuss its fiscal third quarter results on Thursday, July 24, 2025 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com. What:Plexus Fiscal 2025 Q3 Earning ...
Prediction: Buying Federal Realty Today Could Set You Up for Life
The Motley Fool· 2025-07-09 15:23
Group 1: Dividend Attractiveness - Federal Realty offers an attractive dividend yield of 4.6%, significantly higher than the S&P 500's yield of approximately 1.3% and the average REIT yield of 4.1% [2] - The company has increased its dividend annually for 57 consecutive years, earning it the title of Dividend King, a designation for companies that have raised dividends for at least five decades [4] Group 2: Company Overview - Federal Realty is a retail-focused real estate investment trust (REIT) that primarily invests in strip malls and mixed-use developments, catering to consumer needs [6] - The company owns around 100 high-quality properties, which are strategically located in markets with larger populations and greater wealth compared to its peers [7] Group 3: Active Management Strategy - Federal Realty actively manages its portfolio by buying and selling properties, continually investing in them to enhance value [8] - This proactive approach contributes to its impressive dividend record, as the company focuses on constant improvement rather than merely collecting rent [9] Group 4: Market Position - Federal Realty is not frequently available at discounted prices, typically only during significant economic downturns, but its current dividend yield of 4.7% remains historically attractive [10]
NeOnc Technologies Holdings, Inc. Joins Russell Microcap® Index
Globenewswire· 2025-07-09 13:00
CALABASSAS, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, has joined the Russell Microcap® Index following the conclusion of the 2025 Russell indexes annual reconstitution. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks ranking them by total market capitalization. Membership in the Russell Microcap ...
Wix.com (WIX) Suffers a Larger Drop Than the General Market: Key Insights
ZACKS· 2025-07-08 23:01
Company Performance - Wix.com closed at $161.77, reflecting a -1.17% change from the previous day, underperforming the S&P 500's loss of 0.07% [1] - Over the past month, Wix.com shares increased by 6.31%, surpassing the Computer and Technology sector's gain of 5.58% and the S&P 500's gain of 3.94% [1] Upcoming Earnings - Wix.com is projected to report earnings of $1.75 per share, indicating a year-over-year growth of 4.79% [2] - The consensus estimate anticipates revenue of $487.58 million, representing an 11.89% increase from the same quarter last year [2] Annual Estimates - For the annual period, earnings are expected to be $7.13 per share and revenue is projected at $1.98 billion, reflecting increases of +11.58% and +12.7% respectively from the previous year [3] - Recent changes in analyst estimates are crucial as they reflect the shifting dynamics of short-term business patterns, with positive revisions indicating analysts' confidence in business performance [3] Valuation Metrics - Wix.com currently has a Forward P/E ratio of 22.96, which is a premium compared to the industry average Forward P/E of 19.88 [5] - The PEG ratio for Wix.com is 1.11, while the industry average PEG ratio is 2.2 [6] Industry Ranking - The Computers - IT Services industry, which includes Wix.com, ranks in the top 29% of all industries according to the Zacks Industry Rank [6] - The Zacks Industry Rank assesses the strength of industry groups by calculating the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]
eXp(EXPI) - 2022 Q4 - Earnings Call Presentation
2025-07-08 07:46
Financial Performance - Full Year 2022 - eXp World Holdings reported revenue of $4.6 billion, a 22% year-over-year increase[18, 31] - eXp North American Realty contributed $4.55 billion in revenue, representing approximately 99% of eXp World Holdings' total revenue, also a 22% year-over-year increase[18, 31] - eXp International Realty's revenue grew by 102% year-over-year to $36 million[31] - Adjusted EBITDA for eXp World Holdings was positive, although it decreased by 22% year-over-year to $60.5 million[18, 32, 34] - The company's gross margin increased by 24% to $366.9 million[34, 35] Financial Performance - Q4 2022 - Q4 2022 revenue was $933 million, a 13% decrease compared to the previous year[37, 39] - Adjusted EBITDA for Q4 2022 was $3.6 million, a 73% decrease year-over-year[37, 39] - eXp North American Realty's Q4 revenue was $920.7 million, a 14% decrease year-over-year[37] Agent Network and Operational Metrics - The agent count increased by 21% year-over-year, reaching over 86,000 agents[18, 34, 35, 39, 40, 42] - The company's agent Net Promoter Score (aNPS) was 71 for the full year and 73 for Q4[22, 34, 39] - The number of units sold was 511,889 for the full year, a 15% increase year-over-year, but decreased by 13% to 109,168 units in Q4[34, 39]
FTRE SHAREHOLDER ALERT: Suffer Losses on Fortrea Holdings Inc.? Contact BFA Law by August 1 Securities Fraud Class Action Deadline (NASDAQ:FTRE)
GlobeNewswire News Room· 2025-07-06 11:46
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...
FTRE SHAREHOLDERS: The Fortrea Holdings Inc. August 1 Class Action Deadline is Approaching -- Contact BFA Law if You Suffered Losses (NASDAQ:FTRE)
GlobeNewswire News Room· 2025-07-04 12:08
NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...
Biodesix (BDSX) Earnings Call Presentation
2025-07-02 14:40
Company Overview - Biodesix is a leading diagnostics company focused on improving clinical care and patient outcomes[1, 12] - The company's mission is to transform patient care through personalized diagnostics that are timely, accessible, and address immediate clinical needs[13] - Biodesix envisions a world where patient diseases are conquered with the guidance of personalized diagnostics[14] Business Lines and Key Capabilities - Biodesix generates revenue through two business lines: Lung Diagnostic Tests and Development Services[15] - The company expects to have approximately 95 sales representatives focused on lung diagnostics in the field by 4Q25[19] - Biodesix boasts industry-leading gross margins of 794%[19] - Development Services had $109 million in contracts not yet recognized as of the end of Q1 2025[73] Lung Diagnostic Tests - Lung cancer accounts for approximately 1 in 5 cancer deaths annually in the USA[29] - Approximately 80% of patients assessed for lung cancer risk fall into the low to moderate risk category (5-65%)[37, 43] - The Nodify Lung test identifies likely malignant nodules with 78% PPV, 98% specificity, and 28% sensitivity, and identifies likely benign nodules with 98% NPV, 97% sensitivity, and 44% specificity[46] Financial Performance - Total revenue for Q1 2025 was $180 million, representing a 21% year-over-year growth[76, 78] - Lung Diagnostics revenue in Q1 2025 was $163 million, an 18% increase year-over-year[76, 81] - Development Services revenue in Q1 2025 was $17 million, a 61% increase year-over-year[76, 81]